← Back

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions.

Amount
up to $900,000
Type
Grant

Key facts

Key facts for Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Amountup to $900,000
IssuerFood and Drug Administration
Who can applyUS companies
SectorsAgriculture
DeadlineCloses 16 May 2028

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 11 hours ago

  1. 40 days agoagentImported from the official source
Opportunities with the same funding type or region
AI Growth LabCloses 27 Sep 2026
BJA FY 2026 Adult Treatment Court Programup to $2.5MCloses 30 Oct 2026
BJA FY 2026 Capital Case Litigation Initiative: Improving the Quality of Legal Representation in State Capital Casesup to $450,000Closes 29 Oct 2026